US FDA approves Orca Bio's blood cancer therapy
30/06/2026 22:56
US FDA approves Orca Bio's blood cancer therapy June 30 (Reuters) - The U.S. Food and Drug Administration has approved Orca Bio's cell therapy for the treatment of certain blood cancers, the regulator said on Tuesday.
(Reporting by Kunal Das and Puyaan Singh; Editing by Sahal Muhammed)
Recent news on Incyte
See all newsIncyte Corp reports results for the quarter ended September 30 - Earnings Summary
Incyte Q3 adjusted loss per share beats estimates
Revolution Medicines falls after Incyte posts competitive pancreatic cancer data
Factbox: Pharma sector doubles down on AI to slash costs, timelines
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler